Humana Inc [HUM] stock prices are up 0.27% to $259.05 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HUM shares have gain 0.53% over the last week, with a monthly amount glided 5.40%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Humana Inc [NYSE: HUM] stock has seen the most recent analyst activity on December 05, 2025, when Jefferies upgraded its rating to a Buy but kept the price target unchanged to $313 for it. Previously, Goldman started tracking the stock with Sell rating on October 14, 2025, and set its price target to $235. On September 22, 2025, Evercore ISI initiated with a In-line rating and assigned a price target of $295 on the stock. Raymond James upgraded its rating to a Outperform but stick to its price target of $315 on May 01, 2025. BofA Securities upgraded its rating to a Neutral and raised its price target to $308 on November 06, 2024. In a note dated October 08, 2024, Bernstein upgraded an Outperform rating on this stock but restated the target price of $308.
The stock price of Humana Inc [HUM] has been fluctuating between $206.87 and $315.35 over the past year. Currently, Wall Street analysts expect the stock to reach $288.71 within the next 12 months. Humana Inc [NYSE: HUM] shares were valued at $259.05 at the most recent close of the market. An investor can expect a potential return of 11.45% based on the average HUM price forecast.
Analyzing the HUM fundamentals
The Humana Inc [NYSE:HUM] reported sales of 126.36B for trailing twelve months, representing a surge of 11.06%. Gross Profit Margin for this corporation currently stands at 0.23% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.07 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.68.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 257.25 points at the first support level, and at 255.44 for the second support level. However, for the 1st resistance point, the stock is sitting at 261.04, and for the 2nd resistance point, it is at 263.02.
Ratios To Look Out For
It’s worth pointing out that Humana Inc [NYSE:HUM]’s Current Ratio is 2.02. Considering the valuation of this stock, the price to sales ratio is 0.25, the price to book ratio is 1.68 and price to earnings (TTM) ratio is 24.28.
Transactions by insiders
Recent insider trading involved Rechtin James A., President & CEO, that happened on May 14 ’25 when 6530.0 shares were purchased. Former Chief Financial Officer, Diamond Susan M completed a deal on Apr 08 ’25 to buy 10959.0 shares. Meanwhile, Former Chief Administrative Of Huval Timothy S. bought 1247.0 shares on Feb 24 ’25.
